HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Issues in management of diabetic retinopathy.

Abstract
Panretinal photocoagulation could prevent most blindness from proliferative disease--if risk is identified early. This makes it essential that primary physicians include annual ophthalmologic evaluation in the management of patients at risk. Meanwhile, studies are under way on promising medical approaches, including intensive insulin regimens, aldose reductase blockers, and angiogenesis inhibitors.
AuthorsF L Ferris 3rd
JournalHospital practice (Office ed.) (Hosp Pract (Off Ed)) Vol. 28 Issue 5 Pg. 79-82, 85-9 (May 15 1993) ISSN: 8750-2836 [Print] United States
PMID8491803 (Publication Type: Journal Article, Review)
Topics
  • Animals
  • Diabetic Retinopathy (complications, physiopathology, therapy)
  • Humans
  • Light Coagulation
  • Vision Disorders (etiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: